Clinical Trial Update: Biomarkers of AKI in Patients Receiving Daratumumab

View source ↗

Summary

A completed clinical trial update investigating biomarkers of acute kidney injury in patients treated with daratumumab for multiple myeloma, including those wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury
• Light-chain Nephropathy
• Multiple Myeloma

Drugs mentioned

• Daratumumab (daratumumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Acute Kidney Injury, Multiple Myeloma | Status: COMPLETED